Search Results
37 items found for "Tudor Oprea"
- 📰 GPCR Weekly News, September 11 to 17, 2023
of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor
- 📰 GPCR Weekly News, November 20 to 26, 2023
Biological Assays GPCRs in Oncology and Immunology RGS5 maintaining vascular homeostasis is altered by the tumor
- 📰 GPCR Weekly News, November 13 to 19, 2023
Oliver Hartley, was at the PEGS Europe Novartis pays Legend $100M upfront to give solid tumor CAR-T the
- GPCR Buzz of the Week | Sep 23 - 29, 2024
disease GPCRs in Oncology and Immunology Aberrant hormone receptors regulate a wide spectrum of endocrine tumors
- 📰 GPCR Weekly News, January 15 to 21, 2024
death by 72% as first-line treatment for patients with advanced gastroenteropancreatic neuroendocrine tumors
- 📰 GPCR Weekly News, May 29 to June 4, 2023
A2aR on lung adenocarcinoma cells: A novel target for cancer therapy via recruiting and regulating tumor-associated
- Back to GPCR Business: Starting the Year with a Bang! ✴︎ Dec 16, 2024 - Jan 5, 2025
from subcellular compartments Biased agonism at free-fatty acid receptor-4 (FFA4/GPR120) Targeting the tumor
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic
- Decoding β-Arrestins: from Structure to function
However, β-arrestins do not consistently act as oncogenes or tumor suppressors.